AI powered digital service for tracking, supporting and managing obese patients during and after Covid-19

延期影响延期影响请求是基于更改项目的需要，这是对不断发展的新冠肺炎格局的响应。为了加快推向市场的速度，有必要对项目进行修改。这些变化都与项目原来的范围有关。自该项目开始以来，越来越清楚的是，在可预见的未来，为这一高危人群提供面对面的诊所是不可能的。该平台最初的概念是整合虚拟诊所和实际诊所，特别是饮食和活动部分。现在需要以教育电影的形式为这些地区开发具体和详细的虚拟诊所内容，以支持通过电话和视频会议进行临床联系。与其在一段时间内开发这些专业内容，不如立即提供，以便该应用程序在2021年3月之前完全功能，并有强大的内容来支持高危人群。肥胖直接花费英国国民健康保险制度61亿GB和更广泛的英国社会270亿GB。英国有1620万成年人患有临床肥胖症(30.1%)。肥胖与潜在的呼吸系统疾病一起被认为是导致COVID19患者住院率的主要潜在条件风险因素。旨在通过心理、生活方式饮食和药物支持来解决肥胖问题的专业服务在封锁期间基本上暂停，估计有50万使用这些服务的人受到影响，这对这一高危人群的心理和身体健康造成了严重影响。人们对新冠肺炎在这些人群中的进展知之甚少。目前还没有一种远程交付的专家服务，它符合NICE制定的指南，任何临床诊断为肥胖症的人都可以获得。现有的服务提供商面临着与面对面交付相关的高昂管理费用和成本，因此NHS委托的此类服务较少。其中一家这样的服务提供商-这家减肥咨询公司在使用不同的数字技术进行远程交付方面有着成功的记录，并已选择Healum(数字健康技术平台提供商)帮助设计和开发一项针对肥胖者的远程专家远程数字服务，该服务还会对这一高危群体中新冠肺炎的呈现和进展产生洞察。这将使以前访问面对面服务的人在当前和未来的COVID限制期间继续管理自己的健康。同时，通过提高生产率来解决无法获得这些服务的问题，这将使提供商能够降低提供成本，并以更大的能力提供服务。这项技术将提供有价值的见解，了解全国不同的干预和服务组合对临床肥胖者的有效性，以及COVID症状在这一高危群体中的进展和发展。还将测试使用机器学习算法生成每日个性化建议的可行性，以提高生产率。减肥咨询公司将使用患者问卷来评估远程服务的效果。患者报告的结果测量和应用内分析。生产力和容量的变化将通过比较交付前后不同组合的成本来评估，而交付服务的技术可行性将通过开发能够应对500万英国患者和全球5000万患者的平台和基础设施来解决。

Extension to impact An extension to impact request is based upon the need to change the project this is in response to the evolving Covid-19 landscape. The changes to the project are necessary in to increase speed to market. The changes are all related to the original scope of the project. It has become increasingly clear since this project commenced that face to face clinics for this high-risk population will not be possible in the foreseeable future. The original concept of the platform was to integrate virtual and actual clinics specifically the diet and activity components. There is now a need to develop specific and detailed virtual clinic content for these areas in the form of educational films to support clinical contact via telephone and video conferencing. Rather than develop this specialist content over a period of time this needs to be available immediately in order that the app is fully functional by March 2021 and has robust content to support high-risk individuals.Obesity directly costs the NHS £6.1bn and wider UK society £27bn. 16.2 million adults in the UK are clinically obese(30.1%). Obesity has been cited alongside underlying respiratory illnesses as the main underlying condition risk factor in the hospitalisation rate for COVID 19\.Specialist services aimed at tackling obesity through psychological, lifestyle diet and pharmacological support have been largely paused during the lockdown period affecting an estimated 500,000 people that were utilizing these services, which is having a drastic impact on the mental and physical health of this high risk group of the population. Little is known about the progression of Covid-19 amongst this population.There does not exist a remotely delivered specialist service that conforms to the guidelines laid out by NICE that is accessible by anyone who is clinically diagnosed with obesity. Existing service providers face high overheads and costs associated with delivering face to face and the NHS commissions fewer of these services as a result. One such provider of services - The Bariatric Consultancy has had a successful track record in using different digital technologies to deliver remotely and has selected Healum (provider of digital health technology platforms), to help design and develop a remotely specialist remote digital service for obese people that also generates insights around the presentation and progression of COVID-19 amongst this at-risk group .It will enable people who were previously accessing face to face services to continue to manage their health during current and future COVID restrictions, whilst addressing the lack of access to these services through productivity gains that will enable providers to reduce the cost of provision and provide services at a larger capacity.The technology will provide valuable insights about how effective different combinations of interventions and services are across the country for people that are clinically obese, as well as how COVID symptoms progress and develop amongst this high risk group.The feasibility of using machine learning algorithms to generate daily personalised recommendations will also be tested to boost productivity.The efficacy of the remote service will be evaluated by the Bariatric Consultancy using patient questionnaires, patient reported outcome measures and in-app analytics.Changes in productivity and capacity will be evaluated comparing costs of different combinations of delivery before and after, whilst the technical feasibility of delivering the service will be addressed by developing the platform and infrastructure to be able to cope with 5,000,000 uk patients and 50million globally.